Sep 29, 2026
Social drivers of health such as geographic distance, travel burden, or limited availability at specialized patient centers bar many eligible patients from receiving first-line, potentially curative therapies, including chimeric antigen receptor (CAR) T-cell therapy. Community cancer centers in particular often struggle...
Sep 10, 2026
Where a person lives in the United States significantly
influences both the quality of
the cancer care they receive and their treatment outcomes. With a
growing mortality gap
between patients living in urban and rural areas and a distinct
struggle for patients in rural
communities to afford their care, implementing...